PRIVACY POLICY

This Privacy Policy applies to all of your use of Allena Pharmaceutical’s website http://www.allenapharma.com (the “Website”). It describes how your personal information will be treated as you use the Website. Our Privacy Policy is not a contract, and it does not create any legal rights or obligations. We may amend this policy at any time and will provide you notice of any material changes on the Website, by email, or by some other method.

Information We Collect About You

You generally are not required to provide information about yourself when you visit the Website. However, you may choose to register with us in order to receive communications about company news, promotions, products and services, and other features by entering your information on the “Contact Us” page of the Website. In order to register, you will be asked to provide us with information about you including your:

  • first and last name,
  • mailing address,
  • country of residence,
  • telephone number,
  • email address, and
  • whether you are a healthcare provider, patient, member of the media, investor, or other individual.

We also collect information automatically that may be connected to you from the servers used to support the Website. This information includes:

  • the internet protocol (IP) address from which you access the Website,
  • information about the device you use to access the Website,
  • information about the web browser you use to access the Website, and
  • information about applications on your device that are necessary to support the Website.

We use various technical means to collect this information, including application logs on your device or computer, server logs, “cookies” placed on your device or computer, “beacons” in email, and other content.

Information you provide to us may be stored in the United States, Israel, or other jurisdictions that do not provide the same degree of protection for your information as that provided by the United States.

How We Use and Share Your Information
We may use any information we collect about you or about your use of the Website in connection with the operation of our business as well as to improve the Website or to communicate with you about products, features, or services that we believe may be of interest to you or otherwise in connection with our management of the Website. We may also share the information you submit to us to third parties that work with us to offer products and services to our patients as well as to other third parties that offer products or services we believe may be of interest to you. We may also use information we collect about you for the following purposes:

  • security and protection of personnel, assets, and resources;
  • regulatory compliance and monitoring; and
  • compliance with legal requirements or to defend or pursue legal claims.

We may personalize your experience by using your use of the Website to shape any recommendations we may make about content (including advertising) that might be of interest to you. We may also monitor traffic patterns and Website usage to help us develop the design and layout of the Website. We use application logs on your device and our server as well as “cookies” and other tracking technologies for the purposes described above as well as to enhance the functionality of the Website. This information may be stored in files on your device that we access.

We may also use the information we collect to occasionally notify you about functionality changes to the Website, new products or services we provide, and offers we think will be of interest to you. We may create from information we collect from you anonymous demographic information that is not unique to you, such as your ZIP code, domicile, age, gender, preferences, and interests. We may use or permit use of this information with affiliates, advertisers, business partners or unaffiliated third parties for our or their business purposes.

We may transfer information we have about you in connection with a reorganization or combination of our company with another company.

We reserve the right to disclose information we have about you to regulatory authorities, law enforcement agencies, or as required by applicable law.

Choices You Have About Our Use of Your Information

You can write to us at any time to obtain a copy of your information and to have any inaccuracies corrected or if you no longer wish to be registered on the Website. Where appropriate, you may have your personal information erased, rectified, amended or completed. In order to contact us regarding your information, you may call us at 617-467-4577 or send us an email at info@allenapharma.com.

Security and Our Efforts to Protect Your Information

While we have implemented measures designed to protect against the unauthorized access, interception, loss, misuse, and/or alteration of the information under our control, our systems are not designed to protect individually identifiable health information, including protected health information (PHI), or other confidential or sensitive information, and we do not guarantee that events of unauthorized access, interception, loss, misuse, and/or alteration under our control will not occur. In the event of any unauthorized access, interception, or misuse, we will not be responsible for such unauthorized access, interception, or misuse, or any direct, indirect, special, incidental, consequential, or other damages (including lost profits) suffered by a user, even if we have previously been advised of the possibility of such damages. We do not warrant, either expressly or impliedly, that the information provided by any user shall be free from unauthorized access, interception, or misuse. Accordingly, you should use the Website with the express understanding that any information you provide may be compromised.

Confidential Information and Sensitive Personal Information

The Website is not designed to handle any confidential information (including any individually identifiable health information or PHI that is subject to any security requirements under any law), nor is the Website designed to handle information that may not be confidential, but is sensitive personal information such as race or ethnic origin, political opinions, personal finances, religious or other similar beliefs, trade union membership, physical or mental health, educational records, sexual life, or criminal record. You should not use the Website to submit or handle any confidential information or sensitive personal information.

Third Party Sites and Services

When you use the Website, you may directed to other sites outside our service. For example, sections of the Website may include links to third-party sites that we do not operate or control. If you click on one of these links, you will leave the Website. These third-party sites may send their own cookies to users to collect data or solicit personal information. These other sites are not subject to our Privacy Policy and we are not responsible for the privacy policies of these third-party sites, or for the use of any information that these sites may collect.

Your California Privacy Rights

Operators of websites subject to California’s “Shine the Light” law are required to disclose to their California users who obtain products or services from the website operator for family or household use, upon request, the identity of any third parties to who the operator has disclosed personal information for the third parties’ direct marketing purposes within the previous calendar year, along with the type of personal information disclosed.

Children’s Privacy

We are committed to complying with the Children’s Online Privacy Protection Act (COPPA). The Website is not directed to children under the age of 13. We do not knowingly collect personal information from children under the age of 13. If a user identifies themselves as a child under the age of 13, we will not collect, store, or use any personal information. If we receive personal information that we discover was provided by a child under the age of 13, we will promptly destroy such information. Schools and parents should supervise their children’s online activities and consider the use of other means to provide a child-friendly, online environment. Additional information is available on the Direct Marketing Association’s home page at http://ww.the-dma.org. If you would like to learn more about COPPA, visit the U.S. Federal Trade Commission home page at http://www.ftc.gov.

Transfer of Information Across National Borders

You expressly consent to the transfer of your personal information to, and the collection and processing of such personal information in the United States, Israel, and other countries or territories where we or our vendors operate. In giving this consent, you acknowledge that you understand that the laws on holding, processing, using, and transferring personal information in the United States may vary and be less protective of your privacy than laws of your state or country.

How to Contact Us

You may contact us with questions or comments about our Privacy Policy by email at info@allenapharma.com.

Please note that communications to this email address will not constitute legal notice to us or any of our officers, employees, agents, or representatives in any situation where notice to us is required by contract or any law or regulation.

Finally, we urge you to read this Privacy Policy in full as well as our Terms of Use for complete details about our policies concerning the collection and use of your information.

Effective and last updated: May, 2016

Scroll to Top

Jerome Gangitano

Vice President of Manufacturing and Process Development

Jerome Gangitano is the Vice President of Manufacturing and Process Development at Allena Pharmaceuticals. He is an experienced operations executive with more than 30 years of experience in the pharmaceutical and device industries. He has developed, commercialized, and supplied numerous products.

Prior to joining Allena, Jerome was a Site Head at Sanofi where he led a site including Safety and Environmental, Quality, Manufacturing, Process Development – MSAT; Facilities-Engineering, Supply Chain, Materials Purchasing, and Operational Excellence. Prior to his time at Sanofi, Jerome held various leadership positions in Operations, Manufacturing, and Quality at Genzyme, Focal, Johnson & Johnson, and Multiple Peptide Systems. Jerome received his BS in Chemistry from San Diego State University.

Kevin Brennan

Vice President, Finance

Kevin Brennan is the Vice President Finance at Allena Pharmaceuticals. Kevin joined the Allena team in 2011 as the Associate Director, Finance and has played an integral role in financial strategy, planning and operations, and the development and monitoring of systems designed to manage the organization’s finance and reporting. Kevin brings over twenty years of experience in the life science industry. Prior to joining Allena, Kevin held various positions at Alnara Pharmaceuticals, Altus Pharmaceuticals, and Genzyme, where he worked cross-functionally to drive strategic initiatives and optimize planning and reporting processes.

Kevin holds a B.S. in Accounting from Boston College.

Stephen Yu

Senior Vice President, Corporate Quality

Stephen Yu is Senior Vice President of Corporate Quality at Allena Pharmaceuticals. Stephen provides leadership for the internal Quality Assurance and Quality Control functions and oversight across internal and external GxP activities for Allena’s programs and facilities.

Stephen brings over 40 years of drug development and commercialization experience in technical and quality compliance roles. Over the past year, he has worked as Senior Vice President of Quality at Lyndra Therapeutics, a private company based in Watertown. In addition to serving previously as Vice President of Quality Assurance at Allena, Stephen has led his self-directed consultancy, Sky Pharma Consulting, and held prior roles as Vice President of Corporate Quality at Immunogen, as well as roles in Quality and Manufacturing at Genzyme, Merck & Co and Schering-Plough Research Institute.

Stephen earned a B.S. in Chemical Engineering from M.I.T. and an M.B.A. from Rutgers University.

Richard Katz, M.D.

Chief Financial Officer

Richard Katz, M.D. has served as chief financial officer since January 2021. Richard brings to Allena more than 20 years of experience in healthcare finance and corporate development.

Prior to joining Allena, Richard served as the chief financial officer of several biopharmaceutical companies, including Liquidia Technologies, Argos Therapeutics, Viamet Pharmaceuticals and Icagen, Inc. At Icagen, he played an instrumental role in the company’s initial public offering and subsequent financings, the formation of several strategic collaborations and the company’s sale to Pfizer. Richard began his career as a vice president in the healthcare investment banking group at Goldman, Sachs & Company, where he executed a broad range of transactions, including equity and debt financings, mergers and acquisitions, and corporate restructurings.

He holds a B.A. in applied mathematics from Harvard University, an M.D. from the Stanford University School of Medicine and an M.B.A. from Harvard Business School.

Alicja Januszewicz, PhD.

Vice President, People & Culture

Alicja Januszewicz, Ph.D., has served as the Head of People & Culture since 2019. Before joining Allena, she consulted with small organizations in Cambridge within talent management: employee development, organizational development, succession management, high potentials, and workforce planning. Previously, she had served as the Head of Talent Management at Baxalta Innovation Center, where she supported global R&D teams until the Shire acquisition.

Prior to joining Baxalta, Alicja served as Head of Talent Management at Epizyme and Boston Scientific HQ. She also supported the organizational development of Genzyme’s global HR manufacturing group.

Alicja holds a Ph.D. in Sociology from the Polish Academy of Science. She is a graduate of the Talent Management Institute, University of North Carolina, Kenan-Flagler Business School.

David J. Clark, M.D.

Chief Medical Officer

David J. Clark, M.D. has served as Chief Medical Officer since November 2020. He has over 20 years of global industry experience in biopharmaceutical companies based in the United States and Europe.

Before joining Allena, David served as the Chief Medical Officer of Aldeyra Therapeutics, a publicly-traded biotechnology company developing medicines for immune-mediated ocular and systemic diseases. He also served as Chief Medical Officer of Wilson Therapeutics, a privately-held biotechnology company developing novel pharmaceuticals to treat Wilson Disease, a rare autosomal recessive disorder of copper metabolism. David further served as Chief Medical Officer at NormOxys Inc. and TransTech Pharma, LLC. He has held leadership positions at a range of pharmaceutical companies including Pfizer, GlaxoSmithKline, and SmithKline Beecham.

David received his medical degree from the University of Edinburgh, trained in internal medicine, and conducted respiratory medicine academic research.

Geoffrey Swire

Acting Chief Operating Officer and Senior Vice President, Corporate Development

Geoffrey Swire joined Allena in 2018 and currently serves as Acting Chief Operating Officer and Senior Vice President, Corporate Development. Geoffrey has 20 years of leadership experience in business, product, and commercial development for life sciences companies.
 
Geoff previously worked at Radius Health, where he served as head of business development and alliance management, and earlier as program leader for the global Phase 3 osteoporosis development program. Prior to that, Geoff spent seven years at Genzyme, where he held various leadership positions in the Transplant and  Oncology business units, including as head of program and portfolio management, as well as vice president of global commercial operations. Geoff played a central role in the acquisition, development, regulatory approvals, and global commercial launch of Mozobil for patients undergoing stem cell transplants. He started his career in strategy and product development consulting at Integral, Inc., and Accenture’s Health & Life Sciences practice.

Geoff holds a B.A. in French and History from Dartmouth College and a Master’s in Public Policy from Harvard University

Hugh Wight

Senior Vice President, Technical Operations

Hugh Wight is senior vice president of technical operations at Allena Pharmaceuticals. He is an experienced manufacturing executive with more than 20 years in pharmaceutical and biopharmaceutical development, manufacturing, validation and quality assurance.

Prior to joining Allena, Hugh was vice president, technical operations for Alnara Pharmaceuticals, where he led manufacturing, project management, quality assurance and control, and fostered strategic partnerships with manufacturing organizations. Prior to his time at Alnara, Hugh held various quality assurance and validation leadership positions at Altus Pharmaceuticals, Alkermes, Aquila Biopharmaceuticals, AutoImmune and InSite Vision.

Hugh holds a B.S. in microbiology from the University of Maine-Orono.

Louis Brenner, MD

President and Chief Executive Officer

Lou Brenner, MD, has served as chief executive officer of Allena since February 2019 and as president since February 2017. He previously served as chief operating officer from April 2015 to January 2019.

Lou has more than a decade of industry leadership experience, including pharmaceutical development strategy, regulatory affairs, business development, and commercialization. Prior to joining Allena, Lou served as chief medical officer at Idera Pharmaceuticals, chief medical officer at Radius Health, and senior vice president at AMAG Pharmaceuticals. He began his industry career at Genzyme Corporation, where he led successful product development programs for medicines that are currently marketed in the renal and metabolic areas.

He holds an MD from Duke University, an MBA from Harvard Business School, and a BS from Yale University, He completed his residency in internal medicine at Brigham and Women’s Hospital and his fellowship in nephrology at Brigham and Women’s Hospital and Massachusetts General Hospital. Lou holds a clinical appointment at Brigham and Women’s Hospital.